Thursday, April 5, 2012

XenoPort Awarded U.S. Patent Directed to Composition and Formulations of ... - EON: Enhanced Online News (press release)

XenoPort Awarded United States Patent Directed to Composition and Formulations of ... EON: Enhanced Online tidings (press release) ... diagnosis animal studies that compared molar equivalent doses of XP23829 to dimethyl fumarate (DMF), another prodrug of MMF, XP23829 demonstrated type A greater degree of effectiveness in animal models of both multiple sclerosis (MS) and psoriasis . and more » Link To Article

No comments:

Post a Comment